EVAX (Evaxion Biotech AS) Price-to-Tangible-Book : (As of May. 09, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Evaxion Biotech AS Price-to-Tangible-Book?

As of today (2025-05-09), Evaxion Biotech AS's share price is $1.49. Evaxion Biotech AS's Tangible Book per Share of Dec. 2024 for the quarter that ended in Dec. 2024 was $-1.18. Hence, Evaxion Biotech AS's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Evaxion Biotech AS's Price-to-Tangible-Book or its related term are showing as below:

During the past 8 years, Evaxion Biotech AS's highest Price to Tangible Book Ratio was 5.16. The lowest was 3.17. And the median was 4.17.

EVAX's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.58
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Evaxion Biotech AS's share price is $1.49. Evaxion Biotech AS's Book Value per Sharefor the quarter that ended in Dec. 2024 was $-1.18. Hence, Evaxion Biotech AS's P/B Ratio of today is .

Evaxion Biotech AS Price-to-Tangible-Book Historical Data

The historical data trend for Evaxion Biotech AS's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evaxion Biotech AS Price-to-Tangible-Book Chart

Evaxion Biotech AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Tangible-Book

Get a 7-Day Free Trial

3.17

5.16

Evaxion Biotech AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	3.02	12.52	242.97	-

Competitive Comparison of Evaxion Biotech AS's Price-to-Tangible-Book

For the Biotechnology subindustry, Evaxion Biotech AS's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evaxion Biotech AS's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evaxion Biotech AS's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Evaxion Biotech AS's Price-to-Tangible-Book falls into.

Save Embed

;

Save Embed

;

Evaxion Biotech AS Price-to-Tangible-Book Calculation

Evaxion Biotech AS's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2024 )
	=	1.49	/	-1.177
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Evaxion Biotech AS Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Evaxion Biotech AS's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Evaxion Biotech AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evaxion Biotech AS (NAS:EVAX) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

Dr. Neergaards Vej 5f, Hoersholm, DNK, 2970

Website

https://www.evaxion.ai

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are: EVX-01, EVX-03, and EVX-02, which are vaccine candidates being developed for the treatment of various solid cancers. In addition, the company is developing EVX-B1, EVX-B2, EVX-B3, EVX-V1, and multiple other vaccine candidates for various infectious diseases, such as cytomegalovirus, N.gonorrhoeae, bacterial pathogens, and others.